Bubs Australia reaps benefits of US growth strategy
Bubs Australia (ASX:BUB), a maker of goat milk infant formula, organic infant food and toddler snacks, has demonstrated remarkable revenue growth on the back of a resilient US consumer.
Read MoreTag: BUB
Bubs Australia (ASX:BUB) – Webinar Presentation
Reg Weine – CEO & Managing Director – Bubs Australia (ASX:BUB) is on a mission to nourish new generations of happy bubs, with clean label nutritional products that provide the foundation for setting up a lifetime of good eating habits.
Read MoreBubs launches infant formula clinical trial in the US
Bubs Australia (ASX:BUB), a leading infant formula and baby food company, has announced the commencement of a nationwide clinical trial in the United States.
Read MoreBubs Australia focuses on growth
06 Jul 2023 – Bubs Australia (ASX:BUB) has released the findings of its Strategic Review conducted over the past two months.
Read MoreBridge Street Bites: BUB, FLT
Tuesday’s ASX session saw news from infant formula manufacturer Bubs Australia that led to a big selloff, as well as word of an acquisition by travel group Flight Centre.
Read MoreBubs Australia onto a Winning Formula
If there was a given yesterday, it was that Bubs Australia was going to deliver a big revenue jump. And, thanks mainly to its deal with the US government, Bubs didn’t let us down.
Read MoreLike Taking Candy Right Now for Bubs
Happenstance played a big role in the boost to the June quarter performance for Bubs Australia, which was in the right place at the right time with the right product when the US needed it.
Read MoreBourse Discourse: BUB, GAL
Not the easiest of markets in which to raise capital at the moment, but both Bubs Australia and Galileo Mining seemed to have no problems doing so yesterday.
Read MoreBubs Australia (ASX:BUB) enters two new US supply agreements
Bubs Australia (ASX:BUB) has entered into new supply agreements with two retail banner groups in the US, in anticipation of the arrival of plane number four under “operation fly formula”.
Read MoreBubs Growing Up Quickly
The recent deal with the US market is already paying off in spades for Bubs Australia, which today revealed a surge in revenue and earnings for the year to June 30 in a new update.
Read MoreAustralia’s Impact on the U.S. Infant Milk Powder Crisis
Peter Milios looks at whether Bubs Australia and a2Milk are merely a temporary fix to the current US baby formula shortage or set to disrupt an oligopoly within the US market?
Read MoreBubs Locks Down Mother of All Deals, A2 to Follow
Bubs Australia has struck a mega deal to send 1.25 million tins of baby formula to desperate parents in the US, and Monday saw A2 Milk join the rush and offer a deal of its own.
Read MoreTicker Talk: UMG, BUB, EML
Some days companies can release bad news into a strong market and get away with it. As United Malt, Bubs Australia and EML Payments all discovered, yesterday was not one of those days.
Read MoreTrading Tidbits: ARB, BUB, CBA
A busy start to the week for the ASX saw plenty of news doing the rounds on Monday. Here are updates from ARB Corporation, Bubs Australia and the Commonwealth Bank.
Read MoreTrading Tidbits: BUB, PGH, GCY
Good news and bad from the pandemic for two mid-caps yesterday and the shares of the two went in very different directions while an attempted takeover in gold is getting scrappy.
Read MoreBUB – Citi rates the stock as Sell
Citi retains its Sell rating and lowers its target price to $0.33 from $0.35.
Read MoreBUB – Citi rates the stock as Sell
Citi retains its Sell rating on Bubs Australia with a target of $0.51. The broker remains concerned about the structural pressures Australian infant formula market brands are facing.
Read More
